Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

被引：0
|
作者：
Shin, DM
Glisson, BS
Khuri, FR
Hong, WK
Lippman, SM
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 1998年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 44
页数：5
相关论文
共 50 条
  • [1] Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck - Discussion
    Van Oosterom
    Elias
    Haas
    Fields
    Thatcher
    Bokemeyer
    Tursz
    Shad
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (02) : 45 - 48
  • [2] Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
    Adamo, V
    Ferraro, G
    Pergolizzi, S
    Sergi, C
    Laudani, A
    Settineri, N
    Alafaci, E
    Scimone, A
    Spano, F
    Spitaleri, G
    [J]. ORAL ONCOLOGY, 2004, 40 (05) : 525 - 531
  • [3] Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
    Shin, DM
    Glisson, BS
    Khuri, FR
    Ginsberg, L
    Papadimitrakopoulou, V
    Lee, JJ
    Lawhorn, K
    Gillenwater, AM
    Ang, KK
    Clayman, GL
    Callender, DL
    Hong, WK
    Lippman, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1325 - 1330
  • [4] Paclitaxel and ifosfamide-based chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Shin, DM
    Khuri, FR
    Glisson, BS
    Papadimitrakopoulou, V
    Ginsberg, L
    Lippman, SM
    Hong, WK
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (06) : 59 - 59
  • [5] Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
    Shin, DM
    Khuri, FR
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, VM
    Clayman, G
    Lee, JJ
    Ang, KK
    Lippman, SM
    Hong, WK
    [J]. CANCER, 2001, 91 (07) : 1316 - 1323
  • [6] Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, DM
    [J]. SEMINARS IN ONCOLOGY, 2000, 27 (01) : 36 - 40
  • [7] PHASE-I STUDY OF PACLITAXEL, CISPLATIN, AND IFOSFAMIDE IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    BENNER, SE
    LIPPMAN, SM
    HUBER, MH
    HONG, WK
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (05) : 22 - 25
  • [8] A Study Using Ifosfamide and Etoposide in Patients with Cisplatin-refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Huang, Yu-Chung
    Chang, Peter Mu-Hsin
    Chen, Ming-Huang
    Chu, Pen-Yuan
    Tzeng, Cheng-Hwai
    Chang, Shyue-Yih
    Yang, Muh-Hwa
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (05) : 630 - 636
  • [9] Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Thurnher, D
    Kornfehl, J
    Burian, M
    Gedlicka, C
    Selzer, E
    Quint, C
    Neuchrist, C
    Kornek, GV
    [J]. ANTI-CANCER DRUGS, 2001, 12 (03) : 205 - 208
  • [10] Palliative chemotherapy with cisplatin (C) and ifosfamide (I) for recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).
    Fernández, A
    Mesía, R
    Montes, A
    Cardenal, F
    Montes, A
    García, M
    Dotor, E
    Muñoz, M
    Juan, A
    Monner, A
    Galiana, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
12345